USE OF MIRNAS FOR THE DIAGNOSIS, PROPHYLAXIS, TREATMENT AND FOLLOW-UP OF DISEASES INVOLVING MACROAUTOPHAGY ABNORMALITIES

摘要

The invention is use of at least one miRNA (micro Ribonucleic Acid) being member of the hsa-miR-376 family or at least one inhibitor of said miRNA for the diagnosis, prophylaxis, treatment and follow-up during and after treatment of at least one disease involving autophagy abnormalities by acting on autophagy-related genes and proteins; and method thereof.